Caris Life Sciences appointed Brian Brille as vice chairman, Michael Sullivan as chief commercial officer, and Nicholas Nelson as chief business officer. Brille will be responsible for corporate and business development, M&A, and capital markets. He has more than 25 years of experience as a senior financial services executive. Most recently, he was president of Asia Pacific for Bank of America Merrill Lynch. Before that, he was global head of corporate and investment banking at Bank of America.
Before joining Caris, Sullivan was at Roche Diagnostics where he was most recently senior vice president, general manager, and business unit lifecycle leader of the company's core oncology franchise. He also held commercial leadership roles at Johnson & Johnson Ortho-Clinical Diagnostics and Abbott Laboratories' diagnostics division.
Nelson was vice president of commercial and corporate development at Trovagene before joining Caris. He also spent 10 years at Illumina in R&D, technical service, and sales.